Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can mindfulness cut migraine days? new study explores

NCT ID NCT05003362

Symptom relief Sponsor: Brigham and Women's Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a type of mindfulness training called Acceptance and Commitment Therapy (ACT) could help women with frequent migraines. 75 women aged 18-65 with 4-14 migraine days per month took part. The main goal was to see if a larger study was possible, but researchers also looked at whether ACT reduced migraine days and disability.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
mindfulness training (Acceptance and Commitment Therapy)
What this could lead to
If it works, this could offer a non-drug way to help people with migraines have fewer attacks and feel less disabled by them.
What could go wrong
This was a small, early feasibility study with only 75 women, so results may not apply to everyone. It focused on whether the study could be done, not on proving the therapy works.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

75 people

The number who actually took part.

Started

Oct 2020

Finished

Nov 2021

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Women ages 18-65 * Diagnosis of episodic migraine (according to International Classification for Headache Diagnosis criteria) * 4-14 migraine days per month over the past 3 months * No change in medication in the past 3 months * Greater than 1 year of migraines * Agreeable to participate, commit to all study procedures and to be randomized to either group * Fluent in English Exclusion Criteria: * Any unstable medical or psychiatric conditions requiring immediate treatment or could lead to difficulty complying with the protocol * Active suicidal ideation * Moderate to severe depression * Current alcohol or substance abuse * Recent Cognitive Behavioral Therapy, Mindfulness Based Cognitive Therapy, Dialectic Behavioral Therapy or Acceptance and Commitment Therapy within past 3 years * Current use of narcotics * Psychiatric hospitalization within past year * Comorbid pain condition rated as more painful than migraine * Starts new migraine treatment during study * Inability to complete study visits

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Migraine are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

migraine disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Migraine

Contacts and locations

Locations

  • Brigham and Womens Hospital

    Boston, Massachusetts, 02155, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.